Therefore, all MRM results demonstrated that the serum abundance of the six proteins, CELA1, CEL2A, chymopasin, CTRB1, TRY2, and TRY4, reflected tumor development and served as CRC serum biomarkers in this mouse model. The gene discussed is PRSS2; the disease is neoplasm.